
BMGL Technical Analysis Summary (NASDAQ)
Analyze BMGL on the NASDAQ with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerBMGL Technical Analysis Summary (NASDAQ)
Basel Medical Group Ltd Ordinary Shares (NASDAQ: BMGL) stock currently shows a neutral trend on the NASDAQ, supported by momentum and balanced buying pressure.
Technical conditions suggest Basel Medical Group Ltd Ordinary Shares on the NASDAQ is awaiting a decisive move. This mix signals that Basel Medical Group Ltd Ordinary Shares is trading in a balanced range with no clear breakout yet.
RSI (14): 53.64
Stochastic %K: 86.02
Williams %R: -7.47
Rate of Change (ROC): 33.65
Takeaway:Basel Medical Group Ltd Ordinary Shares shows strong bullish momentum, with buyers firmly in control.
MACD: -0.12
ADX: 8.80
ATR (14): 0.48
CCI (14): 109.72
Takeaway:Basel Medical Group Ltd Ordinary Shares shows a neutral trend, with weak conviction and limited volatility.
Takeaway:Basel Medical Group Ltd Ordinary Shares trades closer to resistance, supported by stronger momentum within bands.
Takeaway:Basel Medical Group Ltd Ordinary Shares trades above the trend line, showing healthy momentum within the channel.
Overall Takeaway:BMGL shows bullish money flow, with volume and vigor supporting buyers.
Bullish Signals
RSI above 50 → positive momentum from buyers.
Price trading above middle Bollinger Band → mid-term support intact.
Bearish Signals
MFI above 80 → overbought conditions may limit upside.
Overall Recommendation:Technical indicators for Basel Medical Group Ltd Ordinary Shares are mixed, suggesting a Hold or wait-and-see approach.